FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043398400> ?p ?o ?g. }

• W2043398400 endingPage "399" @default.
• W2043398400 startingPage "393" @default.
• W2043398400 abstract "Abstract Context: Radiation therapy is a potentially curative treatment for corticotroph adenomas refractory to surgery. Protons have an advantage over photons (x-rays) by depositing energy at the target with no exit dose, providing a lower dose to adjacent normal tissues. Until recently, proton stereotactic radiotherapy (PSR) was available at only two U.S. centers; use will increase as proton facilities are under development. Objective: Our objective was to evaluate the efficacy and safety of PSR for persistent Cushing’s disease (CD) and Nelson’s syndrome (NS). Design: This was a retrospective review of 38 patients (33 with CD and five with NS) treated between 1992 and 2005. Participants: All patients had transsphenoidal surgery without biochemical cure. Four had previous irradiation with photons. The patients with NS underwent bilateral adrenalectomy 29–228 months (median 40) before PSR. Intervention: Single-fraction PSR was delivered at a median dose of 20 Cobalt Gray Equivalents (range 15–20) on 1 treatment day. Main Outcome Measures: Complete response (CR) was defined as sustained (≥3 months) normalization of urinary free cortisol off medical therapy. CR in NS was based on normalization of plasma corticotropin. Results: At a median follow-up of 62 months (range 20–136), CR was achieved in five patients (100%) with NS and 17 (52%) patients with CD. Among all patients with CR, median time to CR was 18 months (range 5–49). No secondary tumors were noted on follow-up magnetic resonance imaging scans, and there was no clinical evidence of optic nerve damage, seizure, or brain injury. There were 17 patients (52%) who developed new pituitary deficits. Conclusions: PSR is effective for patients with persistent corticotroph adenomas with low morbidity after a median follow-up of 62 months; longer follow-up is warranted for late radiation-related sequelae." @default.
• W2043398400 created "2016-06-24" @default.
• W2043398400 creator A5001528733 @default.
• W2043398400 creator A5012634740 @default.
• W2043398400 creator A5014884181 @default.
• W2043398400 creator A5017047283 @default.
• W2043398400 creator A5034090492 @default.
• W2043398400 creator A5037784151 @default.
• W2043398400 creator A5044232944 @default.
• W2043398400 creator A5048844031 @default.
• W2043398400 creator A5066793063 @default.
• W2043398400 creator A5076292783 @default.
• W2043398400 date "2008-02-01" @default.
• W2043398400 modified "2023-10-14" @default.
• W2043398400 title "Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas" @default.
• W2043398400 cites W1964198576 @default.
• W2043398400 cites W1967884665 @default.
• W2043398400 cites W1977055483 @default.
• W2043398400 cites W1992446781 @default.
• W2043398400 cites W1997127050 @default.
• W2043398400 cites W1997742570 @default.
• W2043398400 cites W2006660990 @default.
• W2043398400 cites W2007018464 @default.
• W2043398400 cites W2007761389 @default.
• W2043398400 cites W2013080895 @default.
• W2043398400 cites W2024424969 @default.
• W2043398400 cites W2027814107 @default.
• W2043398400 cites W2033031050 @default.
• W2043398400 cites W2035139618 @default.
• W2043398400 cites W2049496736 @default.
• W2043398400 cites W2052939025 @default.
• W2043398400 cites W2066646119 @default.
• W2043398400 cites W2087777302 @default.
• W2043398400 cites W2115570637 @default.
• W2043398400 cites W2137715266 @default.
• W2043398400 cites W2143194787 @default.
• W2043398400 cites W2147438649 @default.
• W2043398400 cites W2150565501 @default.
• W2043398400 cites W2159632410 @default.
• W2043398400 cites W2166878635 @default.
• W2043398400 cites W2341664520 @default.
• W2043398400 doi "https://doi.org/10.1210/jc.2007-1220" @default.
• W2043398400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18029460" @default.
• W2043398400 hasPublicationYear "2008" @default.
• W2043398400 type Work @default.
• W2043398400 sameAs 2043398400 @default.
• W2043398400 citedByCount "99" @default.
• W2043398400 countsByYear W20433984002012 @default.
• W2043398400 countsByYear W20433984002013 @default.
• W2043398400 countsByYear W20433984002014 @default.
• W2043398400 countsByYear W20433984002015 @default.
• W2043398400 countsByYear W20433984002016 @default.
• W2043398400 countsByYear W20433984002017 @default.
• W2043398400 countsByYear W20433984002018 @default.
• W2043398400 countsByYear W20433984002019 @default.
• W2043398400 countsByYear W20433984002020 @default.
• W2043398400 countsByYear W20433984002021 @default.
• W2043398400 countsByYear W20433984002022 @default.
• W2043398400 countsByYear W20433984002023 @default.
• W2043398400 crossrefType "journal-article" @default.
• W2043398400 hasAuthorship W2043398400A5001528733 @default.
• W2043398400 hasAuthorship W2043398400A5012634740 @default.
• W2043398400 hasAuthorship W2043398400A5014884181 @default.
• W2043398400 hasAuthorship W2043398400A5017047283 @default.
• W2043398400 hasAuthorship W2043398400A5034090492 @default.
• W2043398400 hasAuthorship W2043398400A5037784151 @default.
• W2043398400 hasAuthorship W2043398400A5044232944 @default.
• W2043398400 hasAuthorship W2043398400A5048844031 @default.
• W2043398400 hasAuthorship W2043398400A5066793063 @default.
• W2043398400 hasAuthorship W2043398400A5076292783 @default.
• W2043398400 hasBestOaLocation W20433984001 @default.
• W2043398400 hasConcept C126322002 @default.
• W2043398400 hasConcept C126838900 @default.
• W2043398400 hasConcept C143409427 @default.
• W2043398400 hasConcept C151730666 @default.
• W2043398400 hasConcept C2776810848 @default.
• W2043398400 hasConcept C2779134260 @default.
• W2043398400 hasConcept C2779244869 @default.
• W2043398400 hasConcept C2779343474 @default.
• W2043398400 hasConcept C2780087391 @default.
• W2043398400 hasConcept C2989005 @default.
• W2043398400 hasConcept C509974204 @default.
• W2043398400 hasConcept C71924100 @default.
• W2043398400 hasConcept C86803240 @default.
• W2043398400 hasConceptScore W2043398400C126322002 @default.
• W2043398400 hasConceptScore W2043398400C126838900 @default.
• W2043398400 hasConceptScore W2043398400C143409427 @default.
• W2043398400 hasConceptScore W2043398400C151730666 @default.
• W2043398400 hasConceptScore W2043398400C2776810848 @default.
• W2043398400 hasConceptScore W2043398400C2779134260 @default.
• W2043398400 hasConceptScore W2043398400C2779244869 @default.
• W2043398400 hasConceptScore W2043398400C2779343474 @default.
• W2043398400 hasConceptScore W2043398400C2780087391 @default.
• W2043398400 hasConceptScore W2043398400C2989005 @default.
• W2043398400 hasConceptScore W2043398400C509974204 @default.
• W2043398400 hasConceptScore W2043398400C71924100 @default.
• W2043398400 hasConceptScore W2043398400C86803240 @default.
• W2043398400 hasIssue "2" @default.

• next